KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Liabilities and Shareholders Equity (2016 - 2025)

Astrana Health's Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $2.2 billion for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 74.05% year-over-year to $2.2 billion; the TTM value through Sep 2025 reached $5.0 billion, up 7.17%, while the annual FY2024 figure was $1.4 billion, 45.16% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $2.2 billion at Astrana Health, up from $1.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.2 billion in Q3 2025 and bottomed at $843.3 million in Q1 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $982.6 million (2022), against an average of $1.1 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity fell 3.4% in 2023 before it skyrocketed 74.05% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $852.4 million in 2021, then increased by 13.36% to $966.2 million in 2022, then dropped by 3.4% to $933.4 million in 2023, then soared by 45.16% to $1.4 billion in 2024, then surged by 65.12% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Liabilities and Shareholders Equity are $2.2 billion (Q3 2025), $1.4 billion (Q2 2025), and $1.4 billion (Q4 2024).